Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia
Author:
Affiliation:
1. Children's Center for Cancer and Blood Diseases; Children's Hospital of Los Angeles; University of Southern California
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14143/fullpdf
Reference62 articles.
1. Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group;Alexander;Pediatric Blood & Cancer,2014
2. Genetic variegation of clonal architecture and propagating cells in leukaemia;Anderson;Nature,2011
3. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005;Arico;Journal of Clinical Oncology,2010
4. Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions;August;Drugs,2013
5. Drug development: raise standards for preclinical cancer research;Begley;Nature,2012
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preexisting or therapy-induced mutations in relapsed acute lymphoblastic leukemia?;Blood;2020-11-05
2. Identification of co-expressed genes associated with MLL rearrangement in pediatric acute lymphoblastic leukemia;Bioscience Reports;2020-05
3. Bortezomib reinduction chemotherapy in high‐risk ALL in first relapse: a report from the Children's Oncology Group;British Journal of Haematology;2019-04-07
4. NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia;Leukemia;2019-01-11
5. Bortezomib Comes to the Rescue: Comment on the Article by Nachmias et al. Entitled “A Bortezomib-Based Protocol Induces a High Rate of CR with Minor Toxicity in Adult Patients with Relapsed/Refractory ALL”;Acta Haematologica;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3